Navigation Links
Lung Cancer Still Lowest in Federal Funding
Date:5/16/2008

Research Funding Per Death Drops More in 2007

WASHINGTON, May 16 /PRNewswire-USNewswire/ -- While lung cancer causes one in three cancer deaths, the National Cancer Institute (NCI) invested less than 5% of its $4.8 billion budget in lung cancer research in 2007, according to updated statistics issued by Lung Cancer Alliance (LCA) today.

The two other federal agencies with significant cancer research programs -- Centers for Disease Control and Prevention (CDC) and the Department of Defense (DOD) -- have no money earmarked for lung cancer in 2007.

Expressed in dollars per death, research funding through these three federal sources in 2007 totaled $23,754 for breast cancer, $11,959 for prostate cancer and $5,500 for colon cancer. Lung cancer research spending was $1,414 per death, a 23% drop from $1,829 in research funding per death in 2005.

LCA President & CEO Laurie Fenton Ambrose said these statistics paint a clear picture. "Despite lung cancer's enormous death toll, lung cancer research is still not a priority for our public health policy decision makers."

"The lack of public awareness of the statistics and the stigma of smoking has been a shield for those making these decisions, who also know that lung cancer leaves few survivors to demand more federal research funding money," she said.

"To this we say: No More," said Fenton Ambrose, whose Washington D.C. based national organization is the only one dedicated exclusively to patient support and advocacy for those living with or at risk for lung cancer.

Lung cancer has the highest number of deaths and the highest death rate of all the cancers, taking more lives each year than breast, prostate, colon, kidney, and melanoma and liver cancers--combined.

"In addition, very few women even know that lung cancer will kill nearly twice as many women as breast cancer, that the number of women with lung cancer has soared or that one in every five women being diagnosed with lung cancer now has never smoked," said Fenton Ambrose.

Over 50% of new lung cancer patients are former smokers, many of whom quit decades ago. Another 10 to 15% have never smoked, with women non-smokers outnumbering men two to one.

"If women knew all these facts, they would be demanding that lung cancer research be funded at least at the same level as breast cancer research if not more," she said.

In 2007 research funding through NCI, CDC and DOD totaled $971,800,000 for breast cancer, $323,500,000 for prostate cancer, $287,000,000 for colon cancer and $226,900,000 for lung cancer.

In 2007 an estimated 52,180 people will die of colon cancer, 40,460 of breast cancer and 27,050 from prostate cancer. A total of 160,390 will die of lung cancer in 2007.

The 5-year survival rate for breast cancer is now 87%, for prostate cancer 99% and for colon cancer 64%. The 5-year survival rate for lung cancer is 15%.

Statistical report attached and can be viewed at http://www.lungcanceralliance.org.

Lung Cancer Alliance (http://www.lungcanceralliance.org) is the only national non-profit organization dedicated solely to patient support and advocacy for those living with or at risk for lung cancer. LCA is committed to leading the movement to reverse decades of stigma and neglect by empowering those with or at risk for the disease, elevating awareness and changing health policy.

Media Contact:

Kay Cofrancesco

202-463-2080

kay@lungcanceralliance.org


'/>"/>
SOURCE Lung Cancer Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Partnerships Effective Communicators of Cancer Advances
2. Not All Colon Cancer Patients Need Chemotherapy: Study
3. National Coalition for Quality Colorectal Cancer Screening and Care Testifies Before FDA Advisory Panel on Fospropofol Labeling:
4. Bone drug could help prevent the spread of breast cancer
5. Childhood Cancer Survivors Prone to Early Heart Trouble
6. Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy
7. Cancer patients quality of life directly relates to their survival
8. Blood Test Helps Docs Assess Breast Cancer Treatment
9. Low Levels of Vitamin D Spell Trouble for Breast Cancer Patients
10. Novel enzyme inhibitor paves way for new cancer drug
11. Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... The annual time frame to change Medicare health ... is ending December 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their ... D) need to make changes during this period order for their new policy to ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... More than ... and while 84 percent of parents report speaking with their child about sex related ... sexually transmitted diseases. , Mediaplanet is proud to announce the launch of its second ...
(Date:12/2/2016)... ... December 02, 2016 , ... Sourced from the Isbre Springs beneath the 5,000 ... unmatched natural purity of just 6 ppm TDS (Total Dissolved Solids) in addition to ... been available in several ShopRite and FoodTown stores in NJ and received rave comments ...
(Date:12/2/2016)... Miami, FL (PRWEB) , ... December 02, 2016 ... ... over 5,100 hot meals to needy individuals and families from eight different sites ... Florida on Thanksgiving Day. Over 1,000 volunteers worked very hard on Thanksgiving morning ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... they now offer a comprehensive in-house dental plan for all patients. Understanding that ... a plan that gives patients a number of perks, including discounts on many ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... YORK , December 2, 2016 ... Braces & Support) is Expected to Gain a Significant Market ... to Orthopedic Ailments  ... , According to ... Study on Medical Implants Sterile Packaging: Clamshell Product Type Segment ...
(Date:12/2/2016)... On Thursday, the NASDAQ Composite and ... the Dow Jones Industrial Average managed to stay in green. ... which prompted Stock-callers this morning to look at the performances ... NUVA ), Smith & Nephew PLC (NYSE: SNN ... Cesca Therapeutics Inc. (NASDAQ: KOOL ). You can ...
(Date:12/2/2016)... -- The concept of rare diseases and the idea that ... has been taking shape in Europe ... initiatives related to orphan medicinal products have been emerging at ... states individually. Many member states in the EU have led ... medicinal products, the result of which took the shape of ...
Breaking Medicine Technology: